CorVel (CRVL) Q4 2026 Earnings Call Transcript

Image source: The Motley Fool.

DATE

Wednesday, May 20, 2026 at 11:30 a.m. ET

CALL PARTICIPANTS

• President & CEO — Michael Combs
• Chief Financial Officer — Brian Nichols
• [Role Unspecified] — Unknown Executive

Need a quote from a Motley Fool analyst? Email pr@fool.com

TAKEAWAYS

• Quarterly Revenue -- $249 million, marking a 7% increase from the prior year's March quarter.
• Quarterly EPS -- $0.61, up from $0.51, reflecting an increase of approximately 19.6%.
• Full-Year Revenue -- $959 million, up 7% over fiscal year 2025.
• Full-Year EPS -- $2.14, a 17% rise compared to $1.83 in the prior year.
• Effective Tax Rate -- Increased versus the previous year due to nonrecurring discrete stock option benefits.
• Network Solutions Performance -- Delivered double-digit revenue and profit growth, boosted by timing-related post-payment recoveries in CERIS, which contributed $0.02 to EPS.
• Patient Management Segment -- Achieved low single-digit revenue and profit growth, with ongoing investment in service quality and technology modernization.
• New Bookings -- Up 56% year over year, indicating accelerating commercial momentum.
• RFP Activity -- Increased 20%, expanding the business development pipeline.
• Personnel Levels -- Increased to support service and implementations, expected to normalize as further automation and AI enhancements deploy through year-end into 2027.
• Share Repurchases -- 872,744 shares bought for $56 million in the fiscal year, including 366,306 shares for $20 million in the fourth quarter.
• Net Income -- $110 million for the year, up nearly 14% compared to $95 million in fiscal year 2025.
• Quarterly Net Income -- $31 million, an increase of $5 million over the same quarter last year.
• Operating Margin -- 15% for the year, up 1.4 percentage points from the prior fiscal year.
• General & Administrative Expenses -- Decreased $1.3 million year over year in Q4, reducing G&A from 10.6% to 9.4% of revenue.
• Day Sales Outstanding -- Improved by 4 days to 37 days in the March quarter.
• Cash Balance -- Stood at $233 million at fiscal year-end.
• Free Cash Flow -- $66 million for the year, a $7 million increase over fiscal year 2025.
• Share Repurchase History -- 69% of shares repurchased since inception, totaling $868 million at an average price of $7.70 per share, funded via operating cash flow.

SUMMARY

CorVel Corporation (NASDAQ:CRVL) reported multiyear contracts with top national payers that management expects will meaningfully boost revenue and profit as they mature, reflecting a strategic pivot toward enterprise-scale and prepayment solutions. The company disclosed that these new contracts, paired with a growing pipeline and shifting demand to proactive cost management, set up acceleration in the back half of the calendar year. Management emphasized continued investment in artificial intelligence, automation, and platform integration to enhance scalability, reduce manual processing, and support more consistent outcomes. Recent growth in bookings and expanded request for proposal activity further signal heightened client engagement and an expanded addressable market for both CERIS and patient management businesses.

• Michael Combs described CorVel Connected as "brings together artificial intelligence, real-time data integration and embedded clinical and claims expertise into a unified operating model."
• Management identified rising claims severity, medical costs, and complexity as industry trends pushing customers toward integrated, outcome-focused solutions.
• CorVel plans to adjust personnel needs downward over time as automation, AI, and workflow improvements roll out.
• CERIS is transitioning services from postpaid to prepaid flows, supporting a shift to faster, shorter revenue realization cycles of "1 to 2 months for prepaid compared to 6 months or longer for postpaid."
• Management is investing in cybersecurity and operational risk mitigation, citing "The increasing sophistication and speed of AI-driven vulnerability discovery and exploitation" as drivers for enhanced controls.

INDUSTRY GLOSSARY

• CERIS: CorVel’s claims analytics and payment integrity platform offering prepay and postpaid solutions to optimize healthcare claim payment accuracy.
• Prepaid/Postpaid Solutions: Payment integrity methods for claims processing, where 'prepaid' addresses issues before payment and 'postpaid' applies corrections and recoveries after payment is made.
• CorVel Connected: The company’s unified platform integrating artificial intelligence, clinical expertise, and real-time claims data for end-to-end claims management.

Full Conference Call Transcript

Brian Nichols: Thank you, Michael, and good morning, everyone. The March quarter revenues were $249 million, an increase of 7% compared to $232 million in the March 2025 quarter. Earnings per share for the quarter ended March 31, 2026 were $0.61, up from $0.51 in the same period of the previous year. . For the fiscal year 2026, revenues were $959 million, up 7% from $896 million in the prior fiscal year, and earnings per share was $2.14, an increase of 17% compared to $1.83 for the fiscal year ended March 31, 2025. The effective tax rate increased compared to the prior year, which included a discrete benefit from stock option exercises that did not recur at similar levels.

For the fiscal year, Network Solutions delivered strong results with double-digit revenue and profit growth driven by continued momentum across its offerings and solid execution in both property and casualty and commercial health. Results within Network Solutions included the impact of certain onetime events primarily within CERIS, which contributed in part to elevated revenue and profit during the period and added $0.02 of earnings per share. This performance was driven by accelerated post-payment recoveries associated with large payer engagement reflecting a timing-related benefit. Importantly, this engagement, along with these additional large payer wins, is expected to contribute to ongoing revenue and profit tailwinds as these programs scale and mature.

Patient management generated low single-digit revenue and profit growth, reflecting a stable demand environment and consistent focus on operational efficiency. The company is making targeted investments to enhance service quality and consistency as a key differentiator, while advancing systems and technology to support more scalable delivery. Personnel levels increased during the period to support service delivery and implementation activity reflecting near-term execution priorities. These levels are expected to normalize as deployments mature and as automation and AI-enabled workflow enhancements are deployed through the remainder of the year and into 2027, the company expects to realize sustained productivity gains, reduce reliance on manual processes and further improve operating leverage.

Overall, the company's balanced portfolio positions us to deliver scalable growth through network solutions while driving increased differentiation and future growth in patient management through ongoing technology and AI-enabled investments. New bookings in the March quarter increased 56% year-over-year. reflecting high demand and accelerating commercial momentum across the business. RFP activity rose 20% over the same period, supporting steady pipeline expansion. Importantly, these bookings primarily multiyear are expected to contribute meaningfully to revenue and profit growth in the back half of the calendar year as implementation scale.

Michael Combs: Thank you, Brian. Now transitioning to market trends. Health care payers are operating in an increasingly complex environment with rising administrative costs, growing claim complexity and continued pressure to improve financial and clinical outcomes. In response, the market is shifting away from reactive correction towards more proactive models of payment accuracy and cost management. CERIS is well aligned with this shift. Our platform spans both prepay and postpaid solutions, allowing us to improve accuracy earlier in the claims life cycle, while maintaining strong recovery capabilities where needed. This integrated approach enables our customers to reduce downstream work, lower administrative burden and strengthen provider partnerships. We are seeing increasing demand for these capabilities.

In 2026, we are launching 4 large payer programs, including 2 new multiyear partnerships with top 10 national payers. These enterprise scale implementations reinforce the strength of our value proposition and will contribute meaningfully to revenue and profit growth as they mature. The industry also continues to move upstream with prepayment accuracy becoming an increasingly important strategic priority for payers. CERIS is advancing this transition by expanding prepaid solutions and migrating services historically performed postpaid in more proactive workflows. This evolution supports a more predictable and scalable revenue model while delivering earlier intervention and improved operational efficiency for our customers. Looking ahead, we see a healthy and growing pipeline as customers prioritize cost containment, payment accuracy and operational efficiency.

Supported by long-term contracts and expanding adoption of prepaid solutions, we are influencing a shift towards revenue streams with a shorter realization cycle, typically 1 to 2 months for prepaid compared to 6 months or longer for postpaid, while maintaining comparable margin profiles. Combined with intentional investment technology, CERIS is well positioned to deliver sustained scalable growth over time. The technology is a key enabler of this strategy. Our ongoing investment in AI and automation to enhance accuracy, increase throughput and reduce reliance on manual processes. Importantly, our approach focuses on augmenting our teams, providing actionable insights, improving decision-making and enabling clinical and operational professionals to focus on higher-value work.

This combination of technology and domain expertise is a meaningful differentiator and supports both scalability and consistency in outcomes. The workers' compensation and risk management environment continues to evolve in meaningful ways. Across the industry, we are seeing rising claims severity, increased medical costs and greater complexity driven by an aging workforce, increased comorbidities and expanded behavioral health considerations. At the same time, our partners are navigating provider access constraints, regulatory complexity and ongoing pressure to improve outcomes while controlling costs. These dynamics are accelerating a broader shift in the market from transactional cost management towards integrated, outcome-focused claims management supported by real-time data, automation and clinical insights.

At CorVel, we have aligned our strategy and investments to meet this moment. We are advancing CorVel's connected interface within our platform, which brings together artificial intelligence, real-time data integration and embedded clinical and claims expertise into a unified operating model. This platform enables earlier risk identification, faster access to care and more informed decision support throughout the claim continuum. By focusing our use of artificial intelligence on amplifying the work of our teams through workflow automation, predictive insights and next best action guidance, we enable claims and clinical professionals to focus on the most complex and impactful aspects of care. This approach improves outcomes while increasing scalability and productivity in an environment where labor constraints remain a challenge.

One of the key differentiators is the integration of our platform. Rather than operating as a collection of point solutions, CorVel Connected brings together claims clinical pharmacy and network data in real time. This creates continuous feedback across the life cycle of a claim and supports more consistent outcome-driven decision-making. In effect, we are rearchitecting the claims process around actionable intelligence rather than administrative workflow. We are also addressing cost pressures, particularly in medical and slurry and pharmacy spend through clinically driven utilization management, expanded telemedicine capabilities and the development of bundled and episode-based care models. These initiatives are designed to improve both access and quality of care while maintaining appropriate cost control.

At the same time, we are investing in automation, API-driven connectivity and compliance infrastructure to reduce friction, ensure regulatory alignment and enable real-time exchange data across the ecosystem and with our partners, Taken together, these efforts reflect a consistent strategy to move beyond traditional claims administration and deliver a technology-enabled, clinically integrated model focused on total claims outcomes. CorVel is well positioned not only to navigate the current environment but also to gain market share as partners increasingly prioritize scalable, intelligent platforms that deliver both clinical and financial results with greater consistency and transparency. As we further advance automation and AI-enabled capabilities across our platform, the broader operating environment is also evolving rapidly.

The increasing sophistication and speed of AI-driven vulnerability discovery and exploitation are reshaping cybersecurity and operational risk dynamics across the industry. In response, management is further enhancing governance framework, strengthening controls and investing in resilience initiatives designed to support more proactive risk identification and mitigation. These efforts align with growing customer demand for solutions that are adaptive, auditable and durable under heightened operational and regulatory scrutiny. Brian, would you now provide additional texture on the financial results?

Brian Nichols: Certainly, Michael, CorVel's net income for fiscal year 2026 is $110 million. nearly a 14% increase over fiscal year 2025 at $95 million. The fourth quarter contributed $31 million to this year's income total, which is $5 million higher than the same quarter of fiscal year 2025. While the increase in our effective tax rate did temper growth to earnings, much of that increase was offset by business growth among various network solutions products referenced earlier, along with the reduced general and administrative costs. During the fourth quarter, general and administrative expenses decreased by $1.3 million compared to the same quarter of fiscal year 2025, bringing G&A down from 10.6% of revenue to 9.4%.

CorVel's operating margin for the fiscal year 2026 was 15%, which was an improvement of 1.4% over 2025. During the 2026 fiscal year, CorVel repurchased 872,744 shares at a cost of $56 million. 366,306 of the shares were repurchased during the fourth quarter at a cost of $20 million. From inception to date, the company has repurchased 115.3 million shares for an aggregated total of $868 million. Through this program, the company has now repurchased 69% of total shares outstanding at an average price of $7.70 per share. The repurchasing of shares continues to be funded from the company's strong operating cash flow.

CorVel's day sales outstanding was 37 days in the March 2026 quarter, which is an improvement of 4 days compared to the same period of the previous year. At fiscal year-end, the cash balance was $233 million. Free cash flow was $66 million, which is $7 million increase compared to fiscal year 2025. CorVel's robust and debt-free balance sheet uniquely positions us for accelerating strategic product expansion, technological advancement and acquisition opportunities. Our fiscal strategy remains committed to responsible management of financial risks to protect our agility for investing in development. Thank you for your time this morning. I will now invite the operator to open the session for questions.

Operator: [Operator Instructions]

Unknown Executive: Thank you so much, Kevin. We're going to go ahead and return the call to the operator.

Operator: Thank you. There are no questions at this time. Ladies and gentlemen, that does conclude today's teleconference and webcast.

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

The Motley Fool has positions in and recommends CorVel. The Motley Fool has a disclosure policy.